iXledger and fidentiaX Announce Strategic Partnership to Disrupt the Insurance Industry.
iXledger is a ground-breaking alternative marketplace for insurers, reinsurers and brokers to trade insurance products directly and has announced that it has entered into a strategic partnership with fidentiaX, the world’s 1st marketplace for tradable policies powered by blockchain technology.
Both companies are building blockchain solutions to democratize the insurance industry and to streamline the opacity and byzantine operating standards of the sector. fidentiaX’s marketplace empowers Policyholders to monetize their existing insurance policies for higher value and Buyers to invest in an asset class not easily available previously.
This new Strategic Partnership will create synergy between iXledger and fidentiaX platforms to deliver a secured, transparent and efficient end-to-end experience for Businesses (Insurers, Reinsurers, and Brokers) and Consumers (Policyholders).
As part of the partnership, iXledger will be allocating resources towards fidentiaX’s development of its Tradable Insurance Marketplace as well as technology collaboration between the two disruptive marketplaces. fidentiaX’s core team’s experience in the consumer segment strategy and wealth management knowledge will provide iXledger with insights which will enhance the customer experience and delivery of its platform.
“We are excited at the prospect of working with iXledger, their input and experience in the “up-stream” of the insurance lifecycle, will enable us to enhance fidentiaX’s marketplace services and accelerate our objective of empowering policyholders to extract higher value from their policies.” Alvin Ang, Co-founder of fidentiaX
“It is a great opportunity for us to collaborate with fidentiaX with their expertise in the consumer market and their ground-breaking technology. We have already identified a number of synergies and having a partner in a different region with similar goals is a huge advantage.” Ingemar Svensson, Founder/CEO of iXledger
0 Comments
No comments!
There are no comments yet, but you can be first to comment this article.